The FDA has approved the first 2D digital mammography system that lets patients adjust the level of compression applied to their breast during the imaging procedure.
The FDA has approved the first 2D digital mammography system that lets patients adjust the level of compression applied to their breast during the imaging procedure.
Mammograms are a key tool in detecting breast cancer, but some women report discomfort with the procedure as it requires the breast to be compressed in order to capture a 2D x-ray image. However, the new device could potentially expand uptake of mammograms by empowering patients and making the experience more comfortable.
According to the FDA announcement, the Senographe Pristina with Self-Compression, manufactured by GE Healthcare, was approved through the premarket 510(k) pathway. GE had to demonstrate that the new device is clinically equivalent to the Senographe Pristina, an approved digital mammography device that allows the technician operating the device full control over compression.
The Self-Compression device differs from the original machine by including a wireless remote control held by the patient that can adjust the force of compression. After the technologist positions the patient’s breast, the patient is asked to use the remote control to gradually increase the level of compression to a point she finds tolerable. The technician then checks whether the compression is sufficient to achieve a clear image, and can adjust it if necessary.
Trials conducted as part of the premarket approval process confirmed that allowing patients to control compression via the new device’s remote did not worsen image quality compared with the predicate device. It also did not lengthen the average time of the mammogram compared with exams done with the technician applying compression. The finding that the new device was at least as safe and effective as the approved device contributed to the FDA’s decision to grant premarket clearance to GE for the Senographe Pristina with Self-Compression.
“Regular mammograms are an important tool in detecting breast cancer. However, some patients may experience anxiety or stress about the discomfort from the compression during the mammogram,” said Alberto Gutierrez, PhD, director of the Office of In Vitro Diagnostics and Radiological Health at the FDA’s Center for Devices and Radiological Health, in the announcement. “This device allows patients some control over the amount of compression for their exam.”
This sense of control, along with lessened pain and discomfort, could have significant implications for changing women’s perceptions of mammography and their willingness to undergo the screening procedure. A 2013 review published in The Breast found that between 25% and 46% of women who did not return for subsequent mammograms cited pain during the initial mammogram as the reason.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Mammography Use Linked to Social Determinants, Revealing Need to Bridge Gaps With Community Support
April 9th 2024While mammograms are crucial for early detection of breast cancer and can save lives, social determinants of health and health-related social needs create barriers to access, especially for those with financial hardship, lack of transportation, or social isolation.
Read More